Gut bacteria engineered to act as tumor GPS for immunotherapies

E._coli_Bacteria_(7316101966)

Source: NIAID

Cancer researchers have engineered gut derived E. coli bacteria to express immune-activating cytokines on their surfaces, with the idea that the bacteria would move into tumors and induce potent immune responses.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE